HomeANNX • STO
add
Annexin Pharmaceuticals AB (publ)
Previous close
kr 25.00
Day range
kr 24.80 - kr 27.00
Year range
kr 22.10 - kr 63.27
Market cap
186.36M SEK
Avg Volume
2.09K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.40M | -14.48% |
Net income | -9.90M | 9.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.35M | 14.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.88M | 43.82% |
Total assets | 39.51M | 38.16% |
Total liabilities | 4.06M | 15.72% |
Total equity | 35.45M | — |
Shares outstanding | 7.06M | — |
Price to book | 4.98 | — |
Return on assets | -53.05% | — |
Return on capital | -58.18% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -9.90M | 9.40% |
Cash from operations | -9.25M | 20.84% |
Cash from investing | -129.00K | — |
Cash from financing | — | — |
Net change in cash | -9.38M | 19.90% |
Free cash flow | -5.36M | 29.81% |
About
Founded
2014
Website
Employees
4
